PFG
36
3
AEP
48
5
R
67
4
CPB
30
5
ROK
42
4
AMP
66
3
O
33
-4
PM
66
6
TXT
59
6
UNH
55
5
DRI
47
4
BDX
41
3
DIS
52
3
VMC
62
5
CMI
59
14
BK
69
4
MHK
46
3
AVGO
32
7
UPS
28
3
ICE
57
2
PFG
36
3
AEP
48
5
R
67
4
CPB
30
5
ROK
42
4
AMP
66
3
O
33
-4
PM
66
6
TXT
59
6
UNH
55
5
DRI
47
4
BDX
41
3
DIS
52
3
VMC
62
5
CMI
59
14
BK
69
4
MHK
46
3
AVGO
32
7
UPS
28
3
ICE
57
2
Financhill
Back

Akero Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
73

AKRO
Akero Therapeutics

Last Price:
35.32
Seasonality Move:
25.06%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 36% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $32.74. The Score for AKRO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 36% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
73
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
37.00
52-Week Low:
13.39

Prediction Charts

Market Cap:
2.27B
Price in USD:
32.74
Volume:
473.98K
Beta:
-0.28

Technical Analysis

SMA50:
28.46
SMA100:
26.70
SMA200:
24.66
52-Wk Change:
124.55%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 32.74 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 29.82 31.05 31.25 29.82
Oct-18 30.84 31.23 32.15 30.72
Oct-21 30.95 30.90 31.12 30.31
Oct-22 30.55 29.59 31.04 29.57
Oct-23 29.53 28.67 29.97 28.42
Oct-24 28.89 28.75 29.19 28.39
Oct-25 29.15 29.33 29.87 28.96
Oct-28 29.88 29.71 30.83 29.48
Oct-29 29.64 31.73 32.22 29.34
Oct-30 31.52 30.72 32.70 30.69
Oct-31 30.55 30.87 31.43 30.13
Nov-1 31.89 32.33 32.95 30.90
Nov-4 32.20 32.04 32.93 31.50
Nov-5 31.76 32.74 32.75 31.12

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.52 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.